In the present study, the anti-apoptotic effects of various pan-caspase, caspase-3, caspase-8, and caspase-9 inhibitors were investigated in PG-treated Calu-6 and A549 lung cancer cells in relation to changes in ROS and GSH levels. This evidence concerns the gene CASP9 and lung carcinoma.